| EDOJ Contents | Immunohistochemical Study of Some Chemokines in Atopic Epidermis: Extrinsic versus intrinsic types. Ahmad I. Rasheed - Wafaa I. Rasheed* - Maha A-W. Al-Shaarawi **Egyptian Dermatology Online Journal 2 (2):5,
December, 2006. |
AbstractBackground: The atopic reaction is mediated through 3 main types of cells; T-cells, APCs and keratinocytes. The role of these cells is orchestrated by complex interplay of adhesion molecules, cytokines and other inflammatory mediators. Aim of the study: was to semiquantitatively assess expression of some keratinocyte-derived chemokines in the epidermis of atopic skin (acute to subacute lesions) and to explore any differences in the degree and pattern of epidermal expression between intrinsic and extrinsic subsets of AD. Material and methods : Twenty seven cases of atopic dermatitis (16 of the extrinsic and 11 of the intrinsic type) plus 14 control subjects were evaluated immunohistochemically for the epidermal expression pattern and intensity of some chemokines namely TSLP, GM-CSF, TARC, CTACK and RANTES and for LC density in the epidermis. Results: Enhanced expression of TSLP in the lesional epidermis could be seen in ADi group and significantly more in ADe. For GM-CSF, expression was significantly enhanced in the lesional epidermis of ADe only but not in ADi. Lesional skin of both ADi and ADe showed high TARC expression levels but significantly more in ADe than ADi. Expression of both CTACK and RANTES were faint in atopic epidermis and did not differ from that of normal skin. Decrease in the LC count was seen in the lesional skin of both groups but was significant only in the ADe group. The non-lesional atopic epidermis did not show significantly different expression patterns from normal epidermis except for TARC which was significantly enhanced in ADe but not in ADi. Conclusion: The enhanced expression of TSLP, GM-CSF and TARC by atopic epidermis may play a role in the evolution of atopic lesions in general and in the characteristic Th 2 polarization of the inflammatory reaction in particular. The difference in the expression pattern between both subgroups my play a role in determining the exact lineage of the atopic patient (i.e. intrinsic versus extrinsic). TSLP and GM-CSF are likely to augment LC population number and activity in the skin thus increasing the tendency of the skin to react to external allergens which is characteristic of ADe. On the other hand, higher levels of TSLP and TARC in ADe compared to ADi may be responsible for stronger Th 2 polarization of the inflammatory reaction. This may explain some reported differences between ADe and ADi at the tissue or serum levels. Introduction and Aim of the Work:Atopic dermatitis is a chronically relapsing eczematous skin disease resulting from complex interactions between genetic and environmental factors.[1] A large number of immunological and non-immunological abnormalities have been reported in AD patients whether in the skin or serum.[2,3] While the primary defect seems to be genetically determined, many triggering factors have been reported including stress, external irritants, scratching and microbial agents. [4] In spite of controversies as regards the exact pathophysiology of eczematous lesion (and even the exact type of immune reaction), three main types of cells have been confirmed to play the major role in the evolution of characteristic pathology of AD namely T-lymphocytes, antigen presenting cells (APCs) and keratinocytes.[5] The role played by these effector cells is orchestrated by a growing list of cytokines (or chemokines), adhesion molecules and other inflammatory mediators that control trafficking and action of the inflammatory cells and subsequently determine the nature, extent and duration of the inflammatory reaction.[6] In the last few years, more light has been shed on the role of keratinocytes in AD where a lot of constitutive and induced abnormalities have been demonstrated at the immunological (both innate and adaptive) and non- immunological levels (e.g. as regards barrier function and microbial colonization). Immunologically, the expression by epidermal cells of a large number of cytokines has been shown to be dysregulated in atopic skin in general or in lesional areas only. The actions of many of these cytokines could be of significance for the atopic reaction (e.g. for expression of adhesion molecules, recruitment, maturation, survival &/or activation of inflammatory cells especially APCs, determination of the polarity of the reaction and perpetuation of the inflammation).[5] At the same time, the distinction between two subtypes of AD has been recently suggested which are the extrinsic type (ADe) and intrinsic type (ADi). The former type is mainly characterized by elevated serum IgE levels and polyvalent IgE sensitization against inhalant and/or food allergens in skin test or serum while in the intrinsic type, there is no specific IgE sensitization and total serum IgE is not elevated (i.e. <100 kU/L). Other distinctive features of intrinsic AD include later age of onset, mild female predominance, only mild to moderate eosinophilia, lower serum levels of IL-4 and of CD23+ B cells, lower density of tissue eosinophils, lower tissue expression of IL-1 ß , IL-5 and IL-13 as well as Fc RI/Fc RII expression ratio on the CD1a+ epidermal DCs of less than 0.5 in lesional skin. ADi is estimated to represent only 16-45% of all AD cases.[7,8] Although additional differences between these two types are continuously reported whether at the tissue or serum level,[8,9,10] many other aspects of the immune reaction have not yet been explored in a comparative way between both subtypes. The lack of external allergy and of elevated serum IgE levels in the intrinsic group may point to some difference(s) in the evolution pathway between these two subtypes. The aim of the study was to explore other possible differences between ADi and ADe. The study has focused on the immunological role of
keratinocytes and in-particular the expression of some keratinocyte-derived chemokines that could be relevant to the atopic reaction. Material and Methods
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IgE level | Class (& score) |
| (IU/ml) | |
| > 150 | Very strong (4) |
| 151 – 250 | Strong (3) |
| 71 – 150 | Moderate (2) |
| 31 - 70 | Weak (1) |
| 0 - 30 | Undetectable (0) |
Table (1): Scoring of the MAST-CLA test results
Histopathologic and immunohistochemical evaluation:
From each patient a 5 mm-punch biopsy was obtained from both lesional and non-lesional skin, preserved immediately in 10% formalin and subsequently embedded in paraffin blocks. Four micron sections were prepared for subsequent hematoxylin & eosin (H&E) as well as for immunohistochemical staining. One biopsy of normal skin (at matching sites) has been also taken from each control subject.
Histopathologic examination of H&E stained sections was carried out under light microscopy to confirm the diagnosis and to record histopathologic features. The density of the dermal mononuclear infiltrate was given a score of 0 to 6 and the average score of four sections per biopsy was calculated.
(N.B. Only lesions that were judged clinically and confirmed histopathologically to be in the acute or subacute stage were subjected to immunohistochemical evaluation.).
Immunohistochemical Technique
i. Four-micron thick tissue sections cut from the representative paraffin-embedded tissue blocks, overlaid on APES (Sigma, St. Louis, USA) coated slides, were deparaffinized (2 changes of Xylene X 5 minutes each, 1 change of acetone X 1 min) followed by rehydration in decreasing ethanol concentrations (95% ethanol X 3 mins., 70% ethanol X 3 mins., distilled water X 1 min).
ii. For staining with all the antibodies, the tissue sections were then subjected to antigen unmasking by heating the sections immersed in 10 mmol. citrate buffer pH 6.0 (2.1 gm of anhydrous citric acid crystals dissolved in 1L of distilled water and pH adjusted to 6.0, if necessary) inside a 600 watt microwave oven in full power for 35 minutes, allowed to cool to room temperature and then washed briefly with 0.05 M Tris-Hcl buffer pH 7.4.
ii. Endogenous peroxidase activity was then quenched by immersing the sections in methanolic H 2 O 2 (1 part 3% H 2 O 2 plus 4 parts absolute methanol) for 30 minutes. After brief rinsing, the sections were placed in 0.05 M Tris-Hcl buffer pH 7.4 for 10 minutes.
iii. Excess buffer was tapped off followed by a careful wipe around the specimen. Sections were then overlaid with adequate amount of primary antibody diluted optimally using 0.05 M Tris-Hcl buffer pH 7.4 containing 1% bovine serum albumin (Sigma, St. Louis, USA) followed by incubation at 4 0 C overnight.
iv. The slides were then washed with three changes (5 mins each) of 0.05 M Tris-Hcl buffer pH 7.4 followed by incubation for 30 minutes at room temperature after application of biotinylated secondary (link) antibody in phosphate buffered saline containing carrier protein and 15 mmol. sodium azide (LSAB Plus Kit, DAKO, Denmark).
v. After three washings (5 mins each) in Tris-Hcl buffer, peroxidase conjugated streptavidin was applied to cover the specimens and incubated at room temperature for 30 minutes.
vi. Slides were rinsed with 3 changes of Tris-Hcl buffer for 5 mins each. Sections were then covered with substrate chromogen solution prepared freshly by dissolving 1 mg of 3,3 ׳ – diaminobenzidine tetrahydrochloride (Sigma, St. Louis, USA) in 1 ml of 0.05 M Tris-Hcl buffer pH 7.4 containing 1 μl of hydrogen peroxide. The slides were incubated at room temperature for 5 to 10 minutes under microscopic control till the optimal development of brown colored peroxidase reaction product.
vii. After rinsing in distilled water, the sections were lightly counterstained with Harris’ hematoxylin, followed by mounting with cover slips with DPX as mounting medium.
viii. Precaution was taken so that drying of tissue sections strictly did not occur at any time during the entire procedure of immunostaining. All incubations were done inside humid chambers.
ix. Controls: During each batch of staining, positive and negative controls appropriate for the particular antibody were incorporated.
Table (2) shows the details of antibodies utilized in the study.
|
1ry Ab
|
2ry Ab | |||||
| 1ry Ab | Manufacturer | source | Working dilution | Manufacturer | source | Working dilution |
| Anti-TSLP | R&D** | sheep | 2-15 μg/ml | Abcam* | Rabbit | 0.7361111 |
| Anti-TARC | R&D | goat | 5-15 μg/ml | Abcam | Rabbit | 0.7361111 |
| Anti-CTACK | R&D | goat | 15 μg/ml | Abcam | Rabbit | 0.7361111 |
| Anti-Rantes | R&D | goat | 0.5-5 μg/ml | Abcam | Rabbit | 0.7361111 |
| Anti-GM-CSF | Abcam | mouse | 5 μg/ml | Abcam | Rabbit | 0.7361111 |
| Anti-Langerin# | R&D | goat | 2-15 μg/ml | Abcam | Rabbit | 0.7361111 |
Table (2): Primary and secondary antibodies used in the study.
Scoring method:
The scoring method for chemokines was modified from that described by Sinicrope et al. [14] Four sections per specimen have been examined for each marker evaluated in the study using a light microscope equipped with SIS Image Analysis Computer System. The mean percentage of positive tumor cells was determined in at least five fields per section (at 400-fold magnification) and assigned one of the following 8 categories: 0 = <5%; 1 = 5–12.5%; 2 = 12.5–25%; 3 = 25–37.5%; 4 = 37.5-50%, 5 = 50-67.5%, 6 = 67.5-75%, 7 = 75-87.5%, 8 = >87.5%. (N.B. the score refers to the percent of positively stained cells). The intensity of immunostaining was scored as follows: 1+, weak; 2+, moderate; and 3+, intense. Because the lesions showed heterogeneous staining, the dominant pattern was used for scoring. The scores indicating percentage of positive cells and staining intensity were multiplied to produce a weighted score for each field. The average weighted score for the 20 fields examined for each specimen (5 fields/section X 4 sections) is then calculated. Cases with weighted scores <1 were defined as negative, and cases were otherwise defined as positive.
For Langerin reactivity, only the cell with a nucleus and clear immunoreactivity was judged to be a positive cell. Positive cell count only was recorded.
Statistical analysis.
Comparative analysis between two groups was done through unpaired T-test using graphpad software downloaded from the website: http://www.graphpad.com/quickcalcs/ttest1.cfm [15]
Correlation between different parameters was done through graphpad software downloaded from the website:
http://calculators.stat.ucla.edu/correlation.php
[16]
The study included 27 patients suffering from atopic dermatitis (acute to subacute stage) in addition to 14 healthy subjects of matched age and sex as control.
According to the results of laboratory and skin tests, the patients have been divided into 2 subcategories; extrinsic group (16 patients) and intrinsic group (11 patients)
Clinical data of the material of the study and of the biopsied lesions are shown in
table (3)
| CONTROL | TOTAL PATIENTS | EXTRINSIC GROUP | INTRINSIC GROUP | |
| NUMBER | 14 | 27 | 16 | 11 |
| AGE | 10 – 42 | 7 – 43 | 7 – 38 | 10 – 43 |
| (YEARS) | (28.8 +/- 12.2) | (25.7 +/- 11.9) | (23.9 +/- 9.2) | (29.0 +/- 10.2) |
| SEX | 6/8 | 11/16 | 6/10 | 5/6 |
| (M/F) | ||||
| DURATION OF ILLNESS | ------- | 3 MONTHS – 22 YEARS | 3 MONTHS – 22 YEARS | 6 MONTHS – 15 YEARS |
| (MONTH) | ||||
| ASSOCIATED ATOPIC DISORDERS | ------- | 11 cases | 11 cases**: | 0 |
| asthma | ||||
| -7 | ||||
| allergic sinusitis | ||||
| -7 | ||||
| SITE OF BIOPSY | Arm | Arm | Arm | Arm |
| (5) | (11) | (7) | (4) | |
| Thigh | Thigh | Thigh | Thigh | |
| (5) | (10) | (6) | (4) | |
| Back | Back | Back | Back | |
| (3) | (3) | (2) | (1) | |
| Axilla | Axilla | Axilla | Axilla | |
| (1) | (3) | (1) | (2) | |
| DURATION OF BIOPSIED LESIONS (MONTHS) | ----------------- | 1.4 (+/- 1.3) | 1.7 (+/- 0.9) | 1.1 (+/-1.1) |
Table (3): Clinical data of the study material
Results of laboratory tests are shown in tables (4&5).
| CONTROL | TOTAL PATIENTS | EXTRINSIC GROUP | INTRINSIC GROUP | |
| Range | Range | Range | Range | |
| (mean +/- SD) | (mean +/- SD) | (mean +/- SD) | (mean +/- SD) | |
| EOSINOPHILS (percentage in blood) | 1 –6% | 1 – 17% | 7 – 17 % | 1 – 11 % |
| 3.14 +/- 1.7 | 9.1 +/- 4.6 | 12.1 +/- 2.9 | 5.6 +/- 2.3 | |
| TOTAL SERUM IgE | 8 – 66 | 12 – 1560 | 120 – 1560 | 12 – 95 |
| (IU/ml) | (IU/ml) | (IU/ml) | (IU/ml) | (IU/ml) |
| (32.9 +/- 19.5) | (495.8+/- 95.4) | (807.2 +/- 407.8) | (34.6 +/-23.5) |
Table (4): Results of laboratory investigations
| Allergen | Number of +ve cases* | % of +ve cases |
| Mites | 4 | 14.80% |
| Pollen grain | 3 | 11.10% |
| Animal dander | 2 | 7.40% |
| Moulds | 2 | 7.40% |
| Cow’s milk | 3 | 11.10% |
| Egg yolk | 2 | 7.40% |
| Wheat | 2 |